SOLITARIO RESOURCES CORP. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SOLITARIO RESOURCES CORP. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Mar 5, 2021 |
| FY2020 | Dec 31, 2019 | $408.0K | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $502.0K | Mar 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.83M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($5.37M) | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | ($730.0K) | May 2, 2024 |
| FY2024 | Dec 31, 2023 | ($3.75M) | Mar 12, 2025 |
| FY2024 | Mar 31, 2023 | ($380.0K) | May 2, 2024 |
| FY2023 | Dec 31, 2022 | ($3.93M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($2.37M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($939.0K) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($3.29M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($3.60M) | Mar 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.84M | Mar 30, 2015 |
| FY2014 | Dec 31, 2013 | $2.01M | Mar 30, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.57M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($5.10M) | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | ($991.0K) | May 2, 2024 |
| FY2024 | Dec 31, 2023 | ($3.26M) | Mar 12, 2025 |
| FY2024 | Mar 31, 2023 | ($685.0K) | May 2, 2024 |
| FY2023 | Dec 31, 2022 | ($2.90M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($2.16M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($1.01M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($2.64M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($1.36M) | Mar 12, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.03M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $23.04M | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | $25.71M | May 2, 2024 |
| FY2024 | Dec 31, 2023 | $26.76M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $22.03M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $23.62M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $23.80M | Mar 30, 2022 |
| FY2016 | Dec 31, 2016 | $17.61M | Mar 13, 2017 |
| FY2016 | Dec 31, 2015 | $18.05M | Mar 13, 2017 |
| FY2015 | Dec 31, 2014 | $19.04M | Mar 3, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.67M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $22.52M | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | $25.29M | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $25.95M | Mar 11, 2026 |
| FY2024 | Mar 31, 2023 | $21.33M | May 2, 2024 |
| FY2024 | Dec 31, 2022 | $21.65M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $23.18M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $23.50M | Mar 24, 2023 |
| FY2021 | Dec 31, 2019 | $24.13M | Mar 30, 2022 |
| FY2020 | Dec 31, 2018 | $27.09M | Mar 5, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($66.84M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($63.01M) | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | ($58.37M) | May 2, 2024 |
| FY2024 | Dec 31, 2023 | ($57.64M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($53.89M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($49.96M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($47.59M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($46.65M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($43.37M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($40.34M) | Mar 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $82.0K | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $81.0K | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $200.0K | Mar 12, 2025 |
| FY2022 | Dec 31, 2022 | $316.0K | Mar 24, 2023 |
| FY2022 | Dec 31, 2021 | $462.0K | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $605.0K | Mar 30, 2022 |
| FY2021 | Dec 31, 2019 | $574.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2018 | $117.0K | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $214.0K | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $119.0K | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 12, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 12, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 11, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90.90M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 81.64M | Mar 11, 2026 |
| FY2024 | Mar 31, 2024 | 79.64M | May 2, 2024 |
| FY2024 | Dec 31, 2023 | 79.59M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 64.80M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 62.04M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 58.11M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 58.13M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | 58.17M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 58.43M | Mar 1, 2019 |